SS Innovations International In (SSII) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- —
- Estimate
- -$0.01
- Surprise
- —
- Score today
- 5.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Coverage in the report window
- SS Innovations Showcases Robotic Telesurgery Capabilities at International Medical Conferences — fiscal.ai, 2026-10-26
Where TrendMatrix's rating stands now
TrendMatrix currently rates SSII Sell at 5.7/10; no pre/post engine snapshot brackets this report.
0 of the last 1 quarters beat the estimate.
What argues against it
- Quality below floor (2.9 < 4.0)
- Momentum score 4.4/10 — below 4.5 minimum
- Death cross — 50-day MA below 200-day MA
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $2.44
- Price target
- $5.95
- Stop
- $2.27
- Upside to target
- +143.9%
- Reward-to-risk
- 9.6:1
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
SSII at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $489.2M
- P/E (fwd)
- -40.7
- 52-week range
- $2.20–$9.00
- Off 52-week high
- 72.9%
- RSI (14)
- 42
- Volume vs avg
- 0.24×
- Score today
- 5.7/10